Renal Cancer  >>  Inlyta (axitinib)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Inlyta (axitinib) / Pfizer
NCT01056263: Retrospective Observational Study To Update 5-Year Survival Of Subjects Who Participated In Axitinib Trial A4061012

Checkmark P2 data
May 2011 - May 2011: P2 data
Completed
N/A
52
US, Europe
axitinib: observational study, AG-013736
Pfizer
Carcinoma, Renal Cell
12/10
12/10
NCT01473043: Clinical Study With Axitinib In Advanced Kidney Cancer, Who Have Failed First Line Treatment

No Longer Available
N/A
Canada, RoW
Axitinib, AG-013736
Pfizer
Renal Cell Carcinoma
03/14
03/14

Download Options